Cargando…

Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon?

Coronavirus 2019 disease (COVID-19) is associated with coagulation dysfunction that predisposes patients to an increased risk for both arterial (ATE) and venous thromboembolism (VTE) and consequent poor prognosis; in particular, the incidence of ATE and VTE in critically ill COVID-19 patients can re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavoni, Vittorio, Gianesello, Lara, Horton, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109223/ https://www.ncbi.nlm.nih.gov/pubmed/33973157 http://dx.doi.org/10.1007/s11239-021-02470-y

Ejemplares similares

Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Venous thromboembolism and bleeding in critically ill COVID-19 patients treated with higher than standard low molecular weight heparin doses and aspirin: A call to action
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
por: Castillo-Martínez, Diana, et al.
Publicado: (2021)

Deficient mitochondrial biogenesis in critical illness: cause, effect, or epiphenomenon?
por: Levy, Richard J, et al.
Publicado: (2007)

Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
por: Pavoni, Vittorio, et al.
Publicado: (2020)

COVID-19 infection: Is the outcome time-dependent?
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Antiphospholipid antibodies in critically ill patients
por: Vassalo, Juliana, et al.
Publicado: (2014)

Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
por: Pavoni, Vittorio, et al.
Publicado: (2020)

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients
por: Trahtemberg, Uriel, et al.
Publicado: (2021)

Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?
por: Siguret, Virginie, et al.
Publicado: (2020)

Questions about COVID-19 associated coagulopathy: possible answers from the viscoelastic tests
por: Pavoni, Vittorio, et al.
Publicado: (2021)

COVID toes: Phenomenon or epiphenomenon?
por: Deutsch, Alana, et al.
Publicado: (2020)

Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?
por: Shah, Eric, et al.
Publicado: (2014)

Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation
por: van der Linden, Jan, et al.
Publicado: (2020)

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
por: Galeano-Valle, F., et al.
Publicado: (2020)

Human quadrupedalism is not an epiphenomenon caused by neurodevelopmental malformation and ataxia
por: Karaca, Sibel, et al.
Publicado: (2012)

Obesity, Thyroid Nodularity, and Thyroid Cancer: Epiphenomenon or Cause?
por: Bradley, David
Publicado: (2020)

Combined pericapsular nerve group and lateral femoral cutaneous nerve blocks for hip fracture in a polytraumatized patient—A case report
por: Valoriani, Juri, et al.
Publicado: (2022)

Tracheal Intubation with Aura-i and aScope-2: How to Minimize Apnea Time in an Unpredicted Difficult Airway
por: Pavoni, Vittorio, et al.
Publicado: (2015)

Antiphospholipid Antibodies and Multiple Organ Failure in Critically Ill Cancer Patients
por: Salluh, Jorge I. F., et al.
Publicado: (2009)

Left Ventricular Trabeculations in Athletes: Epiphenomenon or Phenotype of Disease?
por: Abela, Mark, et al.
Publicado: (2018)

Antiphospholipid antibodies and COVID-19
por: La Cava, Antonio
Publicado: (2021)

COVID-19 and antiphospholipid antibodies
por: Butt, Ayesha, et al.
Publicado: (2022)

Life Is Simple—Biologic Complexity Is an Epiphenomenon
por: Torday, John S.
Publicado: (2016)

From Epiphenomenon to Biologically Important Phenomena
por: Corr, Philip J, et al.
Publicado: (2018)

SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon?
por: Bonney, Glenn Kunnath, et al.
Publicado: (2020)

Triosephosphate-Isomerase Deficiency: Epiphenomenon or Cause of Loin Pain Haematuria Syndrome?
por: Schurek, Hans-Joachim, et al.
Publicado: (2022)

Pulmonary thromboembolism in critical ill COVID-19 patients
por: Scialpi, Michele, et al.
Publicado: (2020)

Evaluation of the Association between Antiphospholipid Antibodies and ICU Admission Outcome in Critically Ill COVID-19 Patients in Iranian Population
por: Pakzad, Bahram, et al.
Publicado: (2022)

Outcome predictors and quality of life of severe burn patients admitted to intensive care unit
por: Pavoni, Vittorio, et al.
Publicado: (2010)

The Role of Antiphospholipid Antibodies in COVID-19
por: Stelzer, Maximilian, et al.
Publicado: (2021)

Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID
por: Honore, Patrick M., et al.
Publicado: (2021)

The APSANTICO Study: A Prospective Observational Study to Evaluate Antiphospholipid Antibody Profiles in Patients with Thromboembolic Antiphospholipid Syndrome (APS) after COVID-19 Infection and/or Vaccination
por: Ott, Olivia, et al.
Publicado: (2023)

Central sleep apnea: treating the epiphenomenon and neglecting the disease?
por: Perger, Elisa, et al.
Publicado: (2023)

LRRK2 Phosphorylation, More Than an Epiphenomenon
por: Marchand, Antoine, et al.
Publicado: (2020)

Is Bodily Experience an Epiphenomenon of Multisensory Integration and Cognition?
por: Baumard, Josselin, et al.
Publicado: (2019)

Fetal microchimerism, pregnancy epiphenomenon or kinship indicator?
por: Burton, Graham J.
Publicado: (2023)

Hemorrhage and venous thromboembolism in critically ill patients with COVID-19
por: Qiu, Chenyang, et al.
Publicado: (2021)

COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?
por: El Hasbani, Georges, et al.
Publicado: (2020)

The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
por: Previtali, Giulia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e0vjuks87pu7s8i3h20melq07g